New Zealand · Delayed Price · Currency is NZD Oceania Healthcare Earnings Call Transcripts
Fiscal Year 2026
-
Underlying EBITDA rose 23% to $42M, with strong care profitability and cost savings driving results. Gearing improved to 34.8%, and debt reduction is expected to accelerate in the second half, supported by divestments and robust sales momentum.
Fiscal Year 2025
-
The meeting reviewed strong asset growth, a modernized portfolio, and improved financial leverage, but no dividend was declared for FY 2025. Strategic plans focus on care quality, sustainability, and operational efficiency, with robust risk management and board oversight.
-
Positive momentum in FY 2025 with improved sales, cost control, and asset growth. Underlying EBITDA rose 4.1% year-over-year, gearing decreased, and a major cost-out program is underway. Focus remains on sales, debt reduction, and portfolio modernization.
-
Underlying EBITDA rose 2.6% year-over-year, with strong cash inflow and reduced gearing to 37.5%. Focus is on accelerating sales, reducing unsold stock, and achieving NZD 5–7 million in cost savings for FY2026, while dividend resumption depends on sales and gearing.
Fiscal Year 2024
-
The meeting highlighted strong financial growth, strategic portfolio transformation, and a focus on sustainability and risk management. Shareholders discussed share price, dividends, and resident amenities, with the board addressing concerns and outlining future plans for growth and improved services.